HSBC Call 210 AMZN 15.01.2025/ DE000TT9CYH7 /
| 05/06/2024 08:29:20 | Var.+0.09 | Denaro13:49:54 | Lettera13:49:54 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
|---|---|---|---|---|---|---|---|
| 1.47EUR | +6.52% | 1.51 Quantità in denaro: 75,000 |
1.55 Quantità in lettera: 75,000 |
Amazon.com Inc | 210.00 USD | 15/01/2025 | Call |
GlobeNewswire
14:05
Marathon Digital Holdings Announces Bitcoin Production and Mining Operation Updates for May 2024
GlobeNewswire
14:05
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and...
GlobeNewswire
14:00
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
GlobeNewswire
14:00
Scandium International Mining Announces Voting Results from Annual General Meeting of Shareholders
GlobeNewswire
14:00
Navios Maritime Holdings Inc.’s Tender Offer Deadline is Midnight on June 7, 2024 to Receive $4.75 i...
GlobeNewswire
14:00
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
14:00
Lelantos Holdings Announces $1 Million-Plus in Residential Solar Sales for Eco Management Systems Ov...
GlobeNewswire
14:00
Sanas Unveils Free-Forever Noise Cancellation for Contact Center Agents Globally
GlobeNewswire
14:00
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation
GlobeNewswire
14:00
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered...
GlobeNewswire
14:00
Drucker Alumni Pledge $1 Million to Fellowship Fund, Supporting the Next Generation of Business Lead...
GlobeNewswire
14:00
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholde...
GlobeNewswire
14:00
Satelytics Announces Breakthrough in Shoreline Management for Georgia Power Using AI-Powered Geospat...
GlobeNewswire
14:00
VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibito...
